Policy Advisors

About Us

Alexander Tabarrok, Ph.D.

Alex is Bartley J. Madden Chair in Economics at the Mercatus Center at George Mason University and director of research for The Independent Institute.  Tabarrok is co-author with Tyler Cowen of the popular economics blog MarginalRevolution.  His recent research looks at bounty hunters, judicial incentives and elections, crime control, patent reform, methods to increase the supply of human organs for transplant and the regulation of pharmaceuticals. He is the editor of the books Entrepreneurial Economics: Bright Ideas from the Dismal Science, The Voluntary City: Choice, Community, and Civil Society and Changing the Guard: Private Prisons and the Control of Crime. His papers have appeared in the Journal of Law and Economics, Public Choice, Economic Inquiry, Journal of Health Economics, Journal of Theoretical Politics, The American Law and Economics Review, Kyklos and many other journals. Popular articles by Professor Tabarrok have appeared in The New York Times, The Wall Street Journal and many other magazines and newspapers.

Bruce Bloom, J.D., D.D.S

Dr. Bruce Bloom became the Executive Director of Goldman Philanthropic Partnerships, a 501c3 private operating foundation, in February 2002. In 2005, when Goldman Partnerships created the public charity, Partnership for Cures to carry on the Goldman mission, Dr. Bloom became President and Chief Science Officer. Dr. Bloom directs the operation of this public charity dedicated to making a lasting impact on cancer and other diseases by pushing the boundaries of scientific research and creating new methods to fund it.

During more than 20 years of combined business and healthcare experience, Dr. Bloom’s career has spanned law, dentistry, clinical research, insurance, entrepreneurial enterprises, regulatory affairs, product development, and public speaking. Prior to joining the Partnerships, Dr. Bloom was the Senior Vice President-Healthcare Professional Liability at Kemper Casualty Company, a $3 billion insurer headquartered in Long Grove, Illinois . While leading startup operations for the Healthcare Liability Division, he developed and managed cutting edge marketing and sales programs designed to impact B2B and B2C e-commerce and other non-traditional initiatives.  Dr. Bloom has held positions as Director of Loss Control, Vice President and ultimately as the Senior Vice President of CNA HealthPro. In this senior position, Dr. Bloom directed sales and marketing programs and held operational responsibility for the $200 million National Programs Business Unit, which included a staff of more than 50.

During his tenure as Director of Professional Relations and Clinical Affairs at Bausch and Lomb Oral Care Division in Tucker, Georgia, he worked with senior management on a range of multi-million dollar projects involving regulatory affairs, product development, clinical research and professional relations. He also served as Bausch and Lomb’s chief liaison to the American Dental Association and other professional organizations, and managed their Board of Science Advisors.

Dr. Bloom holds a Juris Doctor degree from Chicago Kent College of Law, a Doctor of Dental Surgery degree from University of Illinois Medical Center, and a Bachelor of Science degree in Biology from University of Illinois . He is married and the father of two children.  He is currently the host of a radio program called “Clinician’s Roundtable” on ReachMD, XM 233, the channel for medical professionals.

Henry I. Miller, M.S., M.D.

Dr. Henry Miller is a research fellow at the Hoover Institution, where his research focuses on public policy toward science and technology. It encompasses a number of areas, including pharmaceutical development, the new biotechnology, models for regulatory reform, and the emergence of new viral diseases.

Miller joined the Food and Drug Administration in 1979 and served in a number of posts. He was the medical reviewer for the first genetically engineered drugs evaluated by the FDA and was instrumental in the rapid licensing of human insulin and human growth hormone. Thereafter, he was a special assistant to the FDA commissioner, with responsibility for biotechnology issues, and from 1989 to 1993 was the founding director of the FDA’s Office of Biotechnology. During his government service, Miller participated frequently on various expert and policy panels as a representative of the FDA or the U.S. government. While a government official, Miller was the recipient of numerous awards and citations.

Dr. Miller has published extensively in a broad spectrum of publications worldwide, including The Lancet, Journal of the American Medical Association, Science, the Nature family of journals, Chronicle of Higher Education, Forbes, National Review, Wall Street Journal, New York Times, and Financial Times and has become well known not only for contributions to scholarly journals but also for articles and books that make science, medicine and technology more accessible to nonexperts. 

Miller was short-listed in 2006 by the editors of Nature Biotechnology as one of the personalities who had made the “most significant contributions” to biotechnology during the previous 10 years. Miller serves on numerous editorial boards and is an adjunct scholar at several thinktanks.

Jonathan Baron, Ph.D.

Jonathan Baron is Professor of Psychology at the University of Pennsylvania, where he is also a senior fellow of the Leonard Davis Institute for Health Economics and a member of the Wharton graduate group.  He teaches courses in judgments and decisions and behavioral law and economics.  His former doctoral students include a number of well-known psychologists (Kathie Galotti, Becky Treiman, Hal Pashler, Jackie Persons, Dan Reisberg, Jon Haidt, and the late Jane Beattie).

His research is mainly about intuitions and judgment biases that impede maximization of utility (good) by democratic government. These include parochialism, the act-omission distinction, moralistic values, and the isolation effect.  He is also interested in experimentation and data analysis.

Baron is the author or co-author of five books, including Thinking and Deciding (4th edition, 2008), a widely used textbook for advanced undergraduates and beyond, and Against Bioethics (2006).  He is co-editor of three books, and has published over 180 articles and chapters.  He is founding editor of Judgment and Decision Making, the journal of the Society for Judgment and Decision Making, of which he was president in 2007.

He holds a BA from Harvard (1966) and a PhD from Michigan (1970), and is a Fellow of the American Association for the Advancement of Science and of the Association for Psychological Science.  Baron has applied his knowledge of decision-making to real-world problems, including consulting work with Exxon.  In his youth, he was a political activist, serving as precinct captain, platform-committee chair, and vice-chair of the Ann Arbor Democratic Party, 1967-70.